PharVision Advisers’s Chatham Lodging CLDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-47,427
Closed -$318K 731
2025
Q3
$318K Buy
47,427
+32,399
+216% +$232K 0.18% 193
2025
Q2
$105K Sell
15,028
-14,194
-49% -$99.1K 0.15% 251
2025
Q1
$208K Buy
29,222
+1,135
+4% +$9.4K 0.29% 191
2024
Q4
$251K Buy
+28,087
New +$249K 0.21% 220

Other funds holding CLDT

PharVision Advisers's CLDT Position: Q4 2025 in Review

PharVision Advisers sold out of Chatham Lodging (CLDT) in Q4 2025, closing a stake of 47,427 shares — an estimated $318K sold.

PharVision Advisers first reported a position in CLDT in Q4 2024 and held it in 4 quarters. The position peaked at $318K in Q3 2025. 165 funds tracked by Wall St. Rank hold CLDT as of Q4 2025.

  • PharVision Advisers reported no remaining Chatham Lodging position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 47,427 Chatham Lodging shares in Q4 2025, an estimated $318K.
  • PharVision Advisers first reported a position in Chatham Lodging in Q4 2024 and held it in 4 quarters.
  • PharVision Advisers's Chatham Lodging position peaked at $318K in Q3 2025.
  • 165 funds tracked by Wall St. Rank held Chatham Lodging as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.